Abstract
The death domain serine/threonine kinase RIP interacts with the death receptors Fas and tumor necrosis receptor 1 (TNFR1). In vitro, RIP stimulates apoptosis, SAPK/JNK, and NF-kappaB activation. To define the physiologic role(s) that RIP plays in regulating apoptosis in vivo, we introduced a rip null mutation in mice through homologous recombination. RIP-deficient mice appear normal at birth but fail to thrive, displaying extensive apoptosis in both the lymphoid and adipose tissue and dying at 1-3 days of age. In contrast to a normal thymic anti-Fas response, rip-/- cells are highly sensitive to TNFalpha-induced cell death. Sensitivity to TNFalpha-mediated cell death in rip-/- cells is accompanied by a failure to activate the transcription factor NF-kappaB.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adipose Tissue / pathology
-
Animals
-
Apoptosis*
-
Calcium-Calmodulin-Dependent Protein Kinases
-
Cytokines
-
Failure to Thrive
-
Genes, Lethal
-
JNK Mitogen-Activated Protein Kinases
-
Lymphoid Tissue / pathology
-
Mice
-
Mice, Mutant Strains
-
Mitogen-Activated Protein Kinases*
-
NF-kappa B / metabolism*
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism*
-
Proteins / genetics
-
Proteins / metabolism*
-
Receptor-Interacting Protein Serine-Threonine Kinases
-
Tumor Necrosis Factor-alpha / metabolism*
-
fas Receptor
Substances
-
Cytokines
-
NF-kappa B
-
Proteins
-
Tumor Necrosis Factor-alpha
-
fas Receptor
-
Protein Serine-Threonine Kinases
-
Receptor-Interacting Protein Serine-Threonine Kinases
-
Ripk1 protein, mouse
-
Calcium-Calmodulin-Dependent Protein Kinases
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases